⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28674817 | 0.86 | ALOX5 (0.52) | — | |
| SCHEMBL13475898 | 0.81 | CYP51A1 (0.45) | — | |
| SCHEMBL16748959 | 0.80 | CA1 (0.58) | — | |
| Benzene SCHEMBL28456073 | 0.72 | PTGS2 (0.48) | — | |
| SCHEMBL13475909 | 0.72 | — | — | |
| SCHEMBL13667405 | 0.72 | CA1 (0.52) | — | |
| SCHEMBL15845029 | 0.72 | CA1 (0.52) | — | |
| SCHEMBL13667432 | 0.72 | CA1 (0.52) | — | |
| SCHEMBL13464080 | 0.72 | — | — | |
| SCHEMBL30184791 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117801053-A | Cell membrane protein enrichment method based on phospholipase enzymatic markers | 福建医科大学 | 2024-04-02 | — | — | CN | claimed |
| US-5277772-A | Generating a reactive intermediate | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1994-01-11 | — | — | US | claimed |
| US-20260035341-A1 | FTO INHIBITORS | RPXDS CO LTD (CN) | 2026-02-05 | — | — | US | disclosed |
| EP-4561975-A1 | FTO INHIBITORS | RPXDS Co., Ltd (CN) | 2025-06-04 | — | — | EP | disclosed |
| CN-120058675-A | Preparation and purification method and application of quinoline derivative with biological activity | 河南科技大学 | 2025-05-30 | — | — | CN | disclosed |
| US-20250134890-A1 | ANTIMALARIAL HEXAHYDROPYRIMIDINE ANALOGUES | UCB Biopharma SRL (BE) | 2025-05-01 | — | — | US | disclosed |
| CN-119546566-A | FTO inhibitors | 瑞璞鑫(苏州)生物科技有限公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-113874423-B | Compositions, methods and systems for forming beads using improved polymers | 10X基因组学有限公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-107922387-B | Heterocyclic inhibitors of ERK1 and ERK2 and their use in cancer treatment | 阿沙纳生物科学公司 | 2024-11-22 | — | — | CN | disclosed |
| CN-117801053-A | Cell membrane protein enrichment method based on phospholipase enzymatic markers | 福建医科大学 | 2024-04-02 | — | — | CN | disclosed |
| US-11925629-B2 | Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer | ASANA BIOSCIENCES, LLC (US) | 2024-03-12 | — | — | US | disclosed |
| US-20090118503-A1 | FAAH INHIBITORS | IRONWOOD PHARMACEUTICALS, INC. | 2009-05-07 | — | — | US | disclosed |
| US-20090118503-A1 | FAAH INHIBITORS | IRONWOOD PHARMACEUTICALS, INC. | 2009-05-07 | — | — | US | disclosed |
| WO-2008157740-A2 | FAAH INHIBITORS | IRONWOOD PHARMACEUTICALS, INC. (US) | 2008-12-24 | — | — | WO | disclosed |
| US-20080045585-A1 | Macrocyclic Compounds And Methods Of Making And Using The Same | BioVersys AG (CH) | 2008-02-21 | — | — | US | disclosed |
| US-20080045585-A1 | Macrocyclic Compounds And Methods Of Making And Using The Same | BioVersys AG (CH) | 2008-02-21 | — | — | US | disclosed |
| US-20070191389-A1 | Biaryl derivatives | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2007-08-16 | — | — | US | disclosed |
| CN-1980901-A | Biaryl derivatives | BANYU PHARMA CO LTD (JP) | 2007-06-13 | — | — | CN | disclosed |
| EP-1764362-A1 | BIARYL DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2007-03-21 | — | — | EP | disclosed |
| US-5277772-A | Generating a reactive intermediate | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1994-01-11 | — | — | US | disclosed |